Quick Answer: Current limited evidence does not suggest GLP-1 agonists directly worsen Crohn's disease, but their gastrointestinal side effects may complicate symptom monitoring and disease assessment
(Cianfarani, 2019.) On the GH-IGF-1 axis and tumor growth GH controls IGF-1 production, which happens in the liver
Those with diabetic retinopathy should have appropriate ophthalmologic monitoring when starting semaglutide, as rapid improvement in glucose control may temporarily worsen retinopathy
Over the past year, Lilly increased direct-to-consumer access of Zepbound through its LillyDirect service to counter the limited access offered by CVS Caremark
Because GLP-1 agonists powerfully suppress appetite by resetting hunger signals, they simultaneously engage the same neural networks that sustain substance dependenceoffering a potential explanation for cross-addiction relief
Research has examined DSIP's interactions with corticotropin-releasing hormone (CRH) and ACTH pathways, with investigators studying how the peptide influences stress hormone cascades in both in vitro and animal model systems